JP2021531345A5 - - Google Patents
Info
- Publication number
- JP2021531345A5 JP2021531345A5 JP2021526188A JP2021526188A JP2021531345A5 JP 2021531345 A5 JP2021531345 A5 JP 2021531345A5 JP 2021526188 A JP2021526188 A JP 2021526188A JP 2021526188 A JP2021526188 A JP 2021526188A JP 2021531345 A5 JP2021531345 A5 JP 2021531345A5
- Authority
- JP
- Japan
- Prior art keywords
- tumor
- antigen
- combination product
- optionally
- product according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18183694 | 2018-07-16 | ||
| EP18183694.1 | 2018-07-16 | ||
| EP19170999 | 2019-04-25 | ||
| EP19170999.7 | 2019-04-25 | ||
| PCT/NL2019/050451 WO2020017962A1 (en) | 2018-07-16 | 2019-07-16 | A combination product for use in tumor vaccination. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021531345A JP2021531345A (ja) | 2021-11-18 |
| JP2021531345A5 true JP2021531345A5 (enExample) | 2022-07-12 |
Family
ID=67544309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021526188A Pending JP2021531345A (ja) | 2018-07-16 | 2019-07-16 | 腫瘍ワクチン接種に用いるための組合せ製品 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11071778B2 (enExample) |
| EP (1) | EP3823668A1 (enExample) |
| JP (1) | JP2021531345A (enExample) |
| CA (1) | CA3104833A1 (enExample) |
| WO (1) | WO2020017962A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY202196A (en) | 2017-06-23 | 2024-04-16 | Verimmune Inc | Chimeric virus-like particles and uses thereof as antigen-specific redirectors of immune responses |
| EP3823668A1 (en) | 2018-07-16 | 2021-05-26 | DCPrime B.V. | A combination product for use in tumor vaccination |
| WO2020139978A1 (en) | 2018-12-27 | 2020-07-02 | Verimmune Llc | Conjugated virus-like particles and uses thereof as anti-tumor immune redirectors |
| WO2020217226A1 (en) | 2019-04-25 | 2020-10-29 | Dcprime B.V. | Methods of tumor vaccination |
| WO2021191870A1 (en) | 2020-03-27 | 2021-09-30 | Dcprime B.V. | Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy |
| US20210322471A1 (en) * | 2020-03-27 | 2021-10-21 | Dcprime B.V. | In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy |
| KR20230033647A (ko) * | 2020-06-30 | 2023-03-08 | 멘두스 비.브이. | 난소암 백신에서 백혈병 유래 세포의 용도 |
| AU2021364548A1 (en) | 2020-10-19 | 2023-06-08 | Verimmune Inc. | Virus-inspired compositions and methods of redirecting preexisting immune responses using the same for treatment of cancer |
| WO2022097068A1 (en) * | 2020-11-05 | 2022-05-12 | Dcprime B.V. | Use of tumor-independent antigens in immunotherapies |
| AU2022211682A1 (en) | 2021-01-22 | 2023-08-03 | Mendus B.V. | Methods of tumor vaccination |
| WO2024197451A1 (en) * | 2023-03-24 | 2024-10-03 | Virogin Biotech (Shanghai) Ltd. | Homologous and heterologous therapeutic vaccination strategies for cancer treatment |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO180167C (no) | 1994-09-08 | 1997-02-26 | Photocure As | Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol |
| US5667786A (en) | 1995-06-07 | 1997-09-16 | Novavax, Inc. | Method for treating tumors with a toxin |
| GB9905911D0 (en) | 1999-03-15 | 1999-05-05 | Photocure As | Method |
| EP1246646A2 (en) | 2000-01-05 | 2002-10-09 | Aventis Pasteur Limited | Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen |
| US7118740B1 (en) * | 2000-09-22 | 2006-10-10 | Mayo Foundation For Medical Education And Research | Method for limiting the growth of cancer cells using an attenuated measles virus |
| HU229805B1 (en) | 2000-11-29 | 2014-07-28 | Pci Biotech As | Photochemical internalization for delivery of molecules into the cytosol |
| EP1339862B1 (en) | 2000-11-29 | 2014-01-08 | PCI Biotech AS | Photochemical internalization for virus-mediated molecule delivery into the cytosol |
| JP2004527524A (ja) | 2001-04-05 | 2004-09-09 | カイロン コーポレイション | 非経口初回抗原刺激後の粘膜追加免疫 |
| GB0121023D0 (en) | 2001-08-30 | 2001-10-24 | Norwegian Radium Hospital Res | Compound |
| US20040057935A1 (en) | 2002-09-20 | 2004-03-25 | Cedars-Sinai Medical Center | Intratumoral delivery of dendritic cells |
| JP2006232761A (ja) | 2005-02-25 | 2006-09-07 | Osaka Univ | 制癌剤 |
| JP5052338B2 (ja) | 2005-06-21 | 2012-10-17 | 一般財団法人阪大微生物病研究会 | 癌治療薬 |
| HUE029164T2 (hu) | 2007-09-14 | 2017-02-28 | Univ Brussel Vrije | Humán antigén-prezentáló sejtek T-sejteket stimuláló képességének fokozása és azok alkalmazása vakcinázásra |
| EP2271361A1 (en) | 2008-04-16 | 2011-01-12 | Université de Lausanne | Method and vaccine for optimizing the specific immune responses |
| EP2281030B1 (en) | 2008-05-19 | 2017-01-04 | DCPrime B.V. | Method for inducing and accelerating cells |
| GB0914286D0 (en) | 2009-08-14 | 2009-09-30 | Pci Biotech As | Method |
| CN103179952B (zh) | 2010-09-02 | 2015-06-03 | 斯克里普斯研究学院 | 基于纳米颗粒的肿瘤靶向药物递送 |
| GB201106357D0 (en) * | 2011-04-14 | 2011-06-01 | Pessi Antonello | Composition and uses thereof |
| NL2009102C2 (en) | 2012-07-02 | 2014-01-06 | Dcprime B V | Method for dc-loading. |
| EP2743344A1 (en) | 2012-12-11 | 2014-06-18 | DCPrime B.V. | Therapeutic cancer vaccines derived from a novel dendritic cell line |
| CN105407902A (zh) | 2013-03-05 | 2016-03-16 | 贝勒医学院 | 溶瘤病毒 |
| WO2015073801A1 (en) | 2013-11-14 | 2015-05-21 | Duke University | Tetanus toxoid and ccl3 improve dc vaccines |
| GB201519303D0 (en) * | 2015-11-02 | 2015-12-16 | Imp Innovations Ltd | Phagemid vector |
| BR112019001115A2 (pt) * | 2016-07-21 | 2019-06-25 | Vac4All Pte Ltd | proteínas de biofusão como vacinas anti-malária |
| EP3823668A1 (en) | 2018-07-16 | 2021-05-26 | DCPrime B.V. | A combination product for use in tumor vaccination |
-
2019
- 2019-07-16 EP EP19749853.8A patent/EP3823668A1/en not_active Withdrawn
- 2019-07-16 JP JP2021526188A patent/JP2021531345A/ja active Pending
- 2019-07-16 CA CA3104833A patent/CA3104833A1/en active Pending
- 2019-07-16 WO PCT/NL2019/050451 patent/WO2020017962A1/en not_active Ceased
-
2020
- 2020-04-24 US US16/858,326 patent/US11071778B2/en active Active
-
2021
- 2021-06-29 US US17/361,462 patent/US20220023406A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Jin et al. | Nanoparticle‐mediated delivery of inhaled immunotherapeutics for treating lung metastasis | |
| CN112384205B (zh) | 信使rna疫苗及其用途 | |
| Caldeira et al. | Virus-like particles as an immunogenic platform for cancer vaccines | |
| Rodriguez-Del Rio et al. | A gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection | |
| Raghuwanshi et al. | Dendritic cell targeted chitosan nanoparticles for nasal DNA immunization against SARS CoV nucleocapsid protein | |
| CA3030451C (en) | Compositions and methods for alphavirus vaccination | |
| Su et al. | Induction of mucosal immunity through systemic immunization: Phantom or reality? | |
| Evtushenko et al. | Plant virus particles with various shapes as potential adjuvants | |
| Lin et al. | Programmable macrophage vesicle based bionic self‐adjuvanting vaccine for immunization against monkeypox virus | |
| TWI722858B (zh) | 重組李斯特菌疫苗菌株及產製該菌株之方法 | |
| JP2019536464A5 (enExample) | ||
| JP4472724B2 (ja) | パピロマウイルス偽ウイルス及びその調製方法 | |
| Liu et al. | Functional nanomaterials can optimize the efficacy of vaccines | |
| JP2011519869A5 (enExample) | ||
| WO2008019366A3 (en) | Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens | |
| CY1118080T1 (el) | Σωματιδια απελευθερωσης που ομοιαζουν με ιικα σωματιδια για αυτοαντιγραφικα rna μορια | |
| JP2018536002A5 (enExample) | ||
| JP2022530044A5 (enExample) | ||
| CN103768595B (zh) | 唑来膦酸佐剂及含唑来膦酸佐剂的疫苗 | |
| JP2016513115A5 (enExample) | ||
| JP2015533376A5 (enExample) | ||
| Chakraborty et al. | Ongoing clinical trials of vaccines to fight against COVID-19 pandemic | |
| WO2023049636A3 (en) | Cancer therapy compositions and uses thereof | |
| Cossette et al. | Intranasal subunit vaccination strategies employing nanomaterials and biomaterials | |
| WO2024041612A1 (zh) | 一种正痘病毒属mRNA疫苗及其制备方法和用途 |